146 related articles for article (PubMed ID: 6132291)
1. Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid.
Harenberg J; Zimmermann R; Schwarz F; Kübler W
Lancet; 1983 Apr; 1(8331):986-7. PubMed ID: 6132291
[No Abstract] [Full Text] [Related]
2. The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis.
Rowlings PA; Mansberg R; Rozenberg MC; Evans S; Murray B
Aust N Z J Med; 1991 Feb; 21(1):52-4. PubMed ID: 1709804
[TBL] [Abstract][Full Text] [Related]
3. Use of Org 10,172 in the treatment of heparin-induced thrombocytopenia and thrombosis.
Kiers L; Grigg LE; Cade JF; Street PR; Chong BH
Aust N Z J Med; 1986 Oct; 16(5):719. PubMed ID: 3469977
[No Abstract] [Full Text] [Related]
4. Haemofiltration/haemodialysis in patients with heparin-associated thrombocytopenia.
Chong BH; Jacques T
Intensive Care Med; 1991; 17(7):437. PubMed ID: 1774405
[No Abstract] [Full Text] [Related]
5. Two cases of valvular thrombosis secondary to heparin-induced thrombocytopenia managed without surgery.
Ricome S; Provenchere S; Aubier B; Ajzenberg N; Lepage L; Dilly MP; Dufour G; Montravers P; Longrois D
Circulation; 2011 Mar; 123(12):1355-7. PubMed ID: 21444894
[No Abstract] [Full Text] [Related]
6. Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis.
Ortel TL; Gockerman JP; Califf RM; McCann RL; O'Connor CM; Metzler DM; Greenberg CS
Thromb Haemost; 1992 Mar; 67(3):292-6. PubMed ID: 1379384
[TBL] [Abstract][Full Text] [Related]
7. In vivo activity of a new heparinoid.
Ockelford PA; Carter CJ; Hirsh J
Pathology; 1985 Jan; 17(1):78-81. PubMed ID: 4000717
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: management with a low molecular weight heparinoid.
van Besien K; Hoffman R; Golichowski A
Thromb Res; 1991 Apr; 62(1-2):23-9. PubMed ID: 1712988
[TBL] [Abstract][Full Text] [Related]
9. Heparin-associated thrombocytopenia: successful therapy with the heparinoid Org 10172 in a patient showing cross-reaction to LMW heparins.
Greinacher A; Drost W; Michels I; Leitl J; Gottsmann M; Kohl HJ; Glaser M; Mueller-Eckhardt C
Ann Hematol; 1992 Jan; 64(1):40-2. PubMed ID: 1310879
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia and arterial thrombosis: alternative therapies.
Cola C; Ansell J
Am Heart J; 1990 Feb; 119(2 Pt 1):368-74. PubMed ID: 1689094
[TBL] [Abstract][Full Text] [Related]
11. Thrombosis during the use of the heparinoid Organon 10172 in a patient with heparin-induced thrombocytopenia.
Insler SR; Kraenzler EJ; Bartholomew JR; Kottke-Marchant K; Lytle B; Starr NJ
Anesthesiology; 1997 Feb; 86(2):495-8. PubMed ID: 9054269
[No Abstract] [Full Text] [Related]
12. Heparin-associated thrombocytopenia type II in a patient with end-stage renal disease: successful anticoagulation with the low-molecular-weight heparinoid Org 10172 during haemodialysis.
Greinacher A; Philippen KH; Kemkes-Matthes B; Möckl M; Mueller-Eckhardt C; Schaefer K
Nephrol Dial Transplant; 1993; 8(10):1176-7. PubMed ID: 7505906
[No Abstract] [Full Text] [Related]
13. Clinical use of heparin fractions, fragments, and heparinoids.
Messmore HL
Semin Thromb Hemost; 1985 Apr; 11(2):208-12. PubMed ID: 2412297
[No Abstract] [Full Text] [Related]
14. [Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia].
Anaesthesist; 1998 Nov; 47(11 Suppl Massnahmen):1-4. PubMed ID: 9884734
[No Abstract] [Full Text] [Related]
15. Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172).
Greinacher A; Eckhardt T; Mussmann J; Mueller-Eckhardt C
Thromb Res; 1993 Jul; 71(2):123-6. PubMed ID: 7689764
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan.
Nurmohamed MT; Fareed J; Hoppensteadt D; Walenga JM; ten Cate JW
Semin Thromb Hemost; 1991; 17 Suppl 2():205-13. PubMed ID: 1948091
[No Abstract] [Full Text] [Related]
17. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.
Turpie AG; Gent M; Côte R; Levine MN; Ginsberg JS; Powers PJ; Leclerc J; Geerts W; Jay R; Neemeh J
Ann Intern Med; 1992 Sep; 117(5):353-7. PubMed ID: 1503326
[TBL] [Abstract][Full Text] [Related]
18. [Heparin-induced thrombopenia and thrombosis].
Stöckli TC; Walther A; Görres G; Ritz R; Marbet GA
Schweiz Med Wochenschr; 1996 Mar; 126(12):483-8. PubMed ID: 8650513
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study.
Chong BH; Gallus AS; Cade JF; Magnani H; Manoharan A; Oldmeadow M; Arthur C; Rickard K; Gallo J; Lloyd J; Seshadri P; Chesterman CN;
Thromb Haemost; 2001 Nov; 86(5):1170-5. PubMed ID: 11816702
[TBL] [Abstract][Full Text] [Related]
20. Risk of thrombosis in patients with malignancy and heparin-induced thrombocytopenia.
Opatrny L; Warner MN
Am J Hematol; 2004 Jul; 76(3):240-4. PubMed ID: 15224359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
